CYTOKINETICS INC Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cytokinetics Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Cytokinetics Inc Return On Equity for the quarter ending September 30, 2024 was 335 %, a 76.4% increase year-over-year.
  • Cytokinetics Inc annual Return On Equity for 2023 was 152 %.
  • Cytokinetics Inc annual Return On Equity for 2022 was -1.5K %, a 905% decline from 2021.
  • Cytokinetics Inc annual Return On Equity for 2021 was -149 %, a 59.2% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 335 +145 +76.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 196 -119 -37.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 137 -577 -80.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 152 +1.65K Oct 1, 2023 Dec 31, 2023
Q3 2023 190 +438 Jul 1, 2023 Sep 30, 2023
Q2 2023 315 +435 Apr 1, 2023 Jun 30, 2023
Q1 2023 714 +878 Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.5K -1.35K -905% Oct 1, 2022 Dec 31, 2022
Q3 2022 -248 -43 -21% Jul 1, 2022 Sep 30, 2022
Q2 2022 -120 +59.5 +33.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -165 +48.9 +22.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -149 +217 +59.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -205 +2.86K +93.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -179 -543 -149% Apr 1, 2021 Jun 30, 2021
Q1 2021 -214 -861 -133% Jan 1, 2021 Mar 31, 2021
Q4 2020 -366 -1.87K -124% Oct 1, 2020 Dec 31, 2020
Q3 2020 -3.07K +7.29K +70.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 363 +938 Apr 1, 2020 Jun 30, 2020
Q1 2020 647 +916 Jan 1, 2020 Mar 31, 2020
Q4 2019 1.51K +1.67K Oct 1, 2019 Dec 31, 2019
Q3 2019 -10.4K -10.2K -7143% Jul 1, 2019 Sep 30, 2019
Q2 2019 -575 -454 -375% Apr 1, 2019 Jun 30, 2019
Q1 2019 -269 -170 -171% Jan 1, 2019 Mar 31, 2019
Q4 2018 -168 -71.3 -73.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 -143 -80.3 -128% Jul 1, 2018 Sep 30, 2018
Q2 2018 -121 -108 -843% Apr 1, 2018 Jun 30, 2018
Q1 2018 -99.5 -103 -2744% Jan 1, 2018 Mar 31, 2018
Q4 2017 -96.9 -120 -521% Oct 1, 2017 Dec 31, 2017
Q3 2017 -62.6 -62.8 -60869% Jul 1, 2017 Sep 30, 2017
Q2 2017 -12.8 +56.7 +81.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 3.76 +64.9 Jan 1, 2017 Mar 31, 2017
Q4 2016 23 +73.9 Oct 1, 2016 Dec 31, 2016
Q3 2016 0.1 +25 Jul 1, 2016 Sep 30, 2016
Q2 2016 -69.5 -48.6 -233% Apr 1, 2016 Jun 30, 2016
Q1 2016 -61.2 -43.2 -240% Jan 1, 2016 Mar 31, 2016
Q4 2015 -50.9 -33.1 -187% Oct 1, 2015 Dec 31, 2015
Q3 2015 -24.9 -2.3 -10.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -20.9 +14.9 +41.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -18 +33.4 +65% Jan 1, 2015 Mar 31, 2015
Q4 2014 -17.7 +48.2 +73.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -22.6 +71.3 +75.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 -35.8 +39.5 +52.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 -51.4 +6.22 +10.8% Jan 1, 2014 Mar 31, 2014
Q4 2013 -65.9 -8.79 -15.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -93.9 -31.3 -50.1% Jul 1, 2013 Sep 30, 2013
Q2 2013 -75.3 -5.43 -7.77% Apr 1, 2013 Jun 30, 2013
Q1 2013 -57.6 +28.7 +33.3% Jan 1, 2013 Mar 31, 2013
Q4 2012 -57.1 Oct 1, 2012 Dec 31, 2012
Q3 2012 -62.6 Jul 1, 2012 Sep 30, 2012
Q2 2012 -69.9 Apr 1, 2012 Jun 30, 2012
Q1 2012 -86.3 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.